References
- Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383:2152–67.
- Miller WL, Flück CE. Adrenal cortex and its disorders. In: Sperling MA, editor. Pediatric Endocrinology. 4th ed. Philadelphia, PA: Elsevier; 2014. p. 471–532.
- Wiltshire EJ, Wilson R, Pringle KC. Addison’s disease presenting with an acute abdomen and complicated by cardiomyopathy. J Pediatr Child Health. 2004;40:644–5.
- Derish M, Eckert K, Chin C. Reversible cardiomyopathy in a child with Addison’s disease. Intensive Care Med. 1996;22:460–3.
- Conwell LS, Gray LM, Delbridge RG, Thomsett MJ, Batch JA. Reversible cardiomyopathy in paediatric Addison’s disease – a cautionary tale. J Pediatr Endocrinol Metab. 2003;16:1191–5.
- Sherlock M, Gittoes NJ, Arlt W. Adrenal crisis causing critical illness related reversible myocardial dysfunction. Clin Endocrinol (Oxf). 2008;68:667–9.
- Krishnamoorthy A, Mentz RJ, Hyland KA, McMillan EB, Patel CB, Milano CA, et al. A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison’s disease. ASAIO J. 2013;59:668–70.
- Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24:743–52.
- Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362:192–7.
- Ulate KP, Zimmerman JJ. Common endocrinopathies in the pediatric intensive care unit. In: Fuhrman BP, Zimmerman J, editors. Pediatric Critical Care. 4th ed. Philadelphia, PA: Elsevier; 2011. p. 1105–23.
- Shulman DI, Palmert MR, Kemp SF. Lawson Wilkins Drug and Therapeutics Committee. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;119:e484–94.
- Cleghorn RA. Cardiovascular failure in experimental adrenal insufficiency: a historical revival. Perspect Biol Med. 1983;27:135–55.
- Fallo F, Betterle C, Budano S, Lupia M, Boscaro M, Sonino N. Regression of cardiac abnormalities after replacement therapy in Addison’s disease. Eur J Endocrinol. 1999;140:425–8.
- Kassim TA, Clarke DD, Mai VQ, Clyde PW. Mohamed Shakir, KM. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14:1137–49.
- Pearl JM, Nelson DP, Schwartz SM, Wagner CJ, Bauer SM, Setser EA, et al. Glucocorticoids reduce ischemia-reperfusion induced myocardial apoptosis in immature hearts. Ann Thorac Surg. 2002;74:830–6.
- Messaoudi S, Azibani F, Delcayre C, Jaisser F. Aldosterone, mineralocorticoid receptor, and heart failure. Moll Cell Endocrinol. 2012;350:266–72.